Nargess Hassanzadeh‐Kiabi
Xencor (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Immune Response and Inflammation, Glycosylation and Glycoproteins Research, Advanced Biosensing Techniques and Applications
Most-Cited Works
- → IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil vs monocyte production(2015)130 cited
- → The first trimester human placenta is a site for terminal maturation of primitive erythroid cells(2010)101 cited
- → Blimp-1 Functions as a Molecular Switch to Prevent Inflammatory Activity in Foxp3+RORγt+ Regulatory T Cells(2018)75 cited
- → Detection of a TLR2 agonist by hematopoietic stem and progenitor cells impacts the function of the macrophages they produce(2013)71 cited
- → Autocrine Type I IFN Signaling in Dendritic Cells Stimulated with Fungal β-Glucans or Lipopolysaccharide Promotes CD8 T Cell Activation(2016)34 cited
- → Abstract 5549: Potency-reduced IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity(2020)2 cited
- → 564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agents(2020)1 cited
- → 707 IL12 Fc-fusions engineered for reduced potency and extended half-life exhibit strong anti-tumor activity and improved therapeutic index compared to wild-type IL12 agents(2021)1 cited
- → Abstract 1743: IL12 heterodimeric Fc-fusions engineered for reduced potency exhibit strong anti-tumor activity and improved therapeutic index compared to native IL12 agents(2021)
- → 175 ENHANCING DENDRITIC CELL VACCINES WITH LIGANDS FOR DECTIN-1 AND TOLL-LIKE RECEPTOR-9(2013)